exai bio
Next-generation liquid biopsy company
Hybrid
Some members of the team work remotely, while others are co-located in one or more offices.
👥11-50
📍Palo Alto, California, United States
exai bio
About exai bio
Exai Bio is a next-generation Orphan non-coding RNAs and AI based liquid biospy company.
What exai bio is building
Exai Bio is delivering next-generation liquid biopsy platform for the earliest detection and most accurate cancer diagnosis.
Technologies used at exai bio
Back-end (6)
AWS
Docker
SQL
Python
R
C# Company culture
Integrity
Our thoughts and actions are true to science and to people. We do the right thing.
Openness
We recognize and respect our differences – and embrace learning from them.
Funding rounds
Total Funding
$67.5M
Last funding round type
Series A
Company type
For Profit